On ECHEMI
Home > Drugs > Nanjing Baijingyu Pharmaceutical Co., Ltd.
Nanjing Baijingyu Pharmaceutical Co., Ltd.
  • Founded in:

    1991-07-12
  • Country:

    China China
  • Address:

    No. 1 Huizhong Road, Nanjing Economic and Technological Development Zone
  • Tax NO.:

    9132019213490905XY
  • Registered Funds:

    61.7764 million yuan
  • Website:

  • Email:

Related Drugs
Levonorgestrel drip pills
Each tablet of this product contains 0.75 mg of the main ingredient levonorgestrel. The excipients are: polyethylene glycol 6000, polysorbate 80, and poloxamer.
Name Description Content CAS NO. Registered Holders
Levonorgestrel

Significantly inhibit ovulation and prevent fertilized eggs from implanting, and increase the consistency of cervical mucus and the resistance of sperm penetration, thus playing a quick contraceptive role

More

Significantly inhibit ovulation and prevent fertilized eggs from implanting, and increase the consistency of cervical mucus and the resistance of sperm penetration, thus playing a quick contraceptive role

0.75mg 797-63-7 18
Polyethylene Glycol

This product is a fast-acting, short-acting contraceptive. Its contraceptive mechanism is to significantly inhibit ovulation and prevent the implantation of fertilized eggs, increase the viscosity of cervical mucus, and increase the resistance to sperm penetration, thereby exerting a fast-acting contraceptive effect.

More

This product is a fast-acting, short-acting contraceptive. Its contraceptive mechanism is to significantly inhibit ovulation and prevent the implantation of fertilized eggs, increase the viscosity of cervical mucus, and increase the resistance to sperm penetration, thereby exerting a fast-acting contraceptive effect.

25322-68-3 52
Polysorbate80

This product is a fast-acting, short-acting contraceptive. Its contraceptive mechanism is to significantly inhibit ovulation and prevent the implantation of fertilized eggs, increase the viscosity of cervical mucus, and increase the resistance to sperm penetration, thereby exerting a fast-acting contraceptive effect.

More

This product is a fast-acting, short-acting contraceptive. Its contraceptive mechanism is to significantly inhibit ovulation and prevent the implantation of fertilized eggs, increase the viscosity of cervical mucus, and increase the resistance to sperm penetration, thereby exerting a fast-acting contraceptive effect.

0
POLOXAMER124

This product is a fast-acting, short-acting contraceptive. Its contraceptive mechanism is to significantly inhibit ovulation and prevent the implantation of fertilized eggs, increase the viscosity of cervical mucus, and increase the resistance to sperm penetration, thereby exerting a fast-acting contraceptive effect.

More

This product is a fast-acting, short-acting contraceptive. Its contraceptive mechanism is to significantly inhibit ovulation and prevent the implantation of fertilized eggs, increase the viscosity of cervical mucus, and increase the resistance to sperm penetration, thereby exerting a fast-acting contraceptive effect.

0
Niacin Tablets
The main ingredient of this product is: niacin.
Name Description Content CAS NO. Registered Holders
Nicotinic acid

Nicotinic acid is converted into nicotinamide in the body, and then combined with riboadenin to form nicotinamide adenine dinucleotide (coenzyme I) and nicotinamide adenine dinucleotide phosphate (coenzyme II), which are necessary for lipid amino acid, protein, purine metabolism, tissue respiration oxidation and glycogenolysis. Nicotinic acid can reduce the utilization of coenzyme A; by inhibiting the synthesis of very low density lipoprotein (VLDL), it affects the transport of cholesterol in the blood. Large doses can reduce serum cholesterol and triglyceride concentrations. Nicotinic acid has a peripheral vasodilation effect.

More

Nicotinic acid is converted into nicotinamide in the body, and then combined with riboadenin to form nicotinamide adenine dinucleotide (coenzyme I) and nicotinamide adenine dinucleotide phosphate (coenzyme II), which are necessary for lipid amino acid, protein, purine metabolism, tissue respiration oxidation and glycogenolysis. Nicotinic acid can reduce the utilization of coenzyme A; by inhibiting the synthesis of very low density lipoprotein (VLDL), it affects the transport of cholesterol in the blood. Large doses can reduce serum cholesterol and triglyceride concentrations. Nicotinic acid has a peripheral vasodilation effect.

59-67-6 15
Ketoconazole cream
Each gram of this product contains 0.02 grams of the main ingredient ketoconazole, and the auxiliary materials are: cetyl alcohol, stearyl alcohol, glyceryl monostearate, stearic acid, white vaseline, liquid paraffin, glycerin, sodium lauryl sulfate, vitamin C, ethyl hydroxybenzoate, and polyethylene glycol 400.
Name Description Content CAS NO. Registered Holders
Ketoconazole

Ketoconazole is an azole antifungal drug. It has antibacterial and bactericidal effects on dermatophytes, yeasts (Candida, Pityrosporum, Torulopsis, Cryptococcus), dimorphic fungi and Fungi; except for Entomophthora, it has weaker effects on Aspergillus, Schenckia, some Phaeochromocytaceae, and Mucor. The mechanism of action of ketoconazole is mainly to highly selectively interfere with the activity of fungal cytochrome P-450, thereby inhibiting the biosynthesis of ergosterol on the fungal cell membrane.

More

Ketoconazole is an azole antifungal drug. It has antibacterial and bactericidal effects on dermatophytes, yeasts (Candida, Pityrosporum, Torulopsis, Cryptococcus), dimorphic fungi and Fungi; except for Entomophthora, it has weaker effects on Aspergillus, Schenckia, some Phaeochromocytaceae, and Mucor. The mechanism of action of ketoconazole is mainly to highly selectively interfere with the activity of fungal cytochrome P-450, thereby inhibiting the biosynthesis of ergosterol on the fungal cell membrane.

0.02g 65277-42-1 25
Cinnarizine Tablets
Main component: 1-diphenylmethyl-4-(3-phenyl-ethyl-propylene)-piperazine, molecular formula: C26H28N2, molecular weight: 368.52.
Name Description Content CAS NO. Registered Holders
1-Benzhydryl-4-(3-phenyl-ethyl-propenyl)-piperazine

This product is a piperazine calcium channel antagonist that can block calcium influx into vascular smooth muscle, causing vasodilation and improving cerebral and coronary circulation, especially having a certain selective effect on cerebral blood vessels. This product can inhibit phosphodiesterase, prevent cAMP from decomposing into inactive 5-AMP, thereby increasing the intracellular cAMP concentration, inhibiting the release of histamine, 5-hydroxytryptamine, bradykinin and other biologically active substances, and also inhibiting the activation of complement C4.

More

This product is a piperazine calcium channel antagonist that can block calcium influx into vascular smooth muscle, causing vasodilation and improving cerebral and coronary circulation, especially having a certain selective effect on cerebral blood vessels. This product can inhibit phosphodiesterase, prevent cAMP from decomposing into inactive 5-AMP, thereby increasing the intracellular cAMP concentration, inhibiting the release of histamine, 5-hydroxytryptamine, bradykinin and other biologically active substances, and also inhibiting the activation of complement C4.

0
Dimenhydrinate Tablets
The main ingredients of this product are dimenhydrinate, and its chemical name is: 1,3-dimethyl-8-chloro-1H-2,6-dione and N,N-dimethyl-2-(diphenylmethoxy)ethylamine.
Name Description Content CAS NO. Registered Holders
Dimenhydrinate

This product has a rapid effect and is one of the most potent topical corticosteroids currently used in clinical practice. It has a strong capillary constriction effect, and its anti-inflammatory effect is 112.5 times that of hydrocortisone, 2.3 times that of betamethasone sodium phosphate, and 18.7 times that of fluocinolone. The systemic adverse reactions are 3 times that of fluocinolone, and it has no sodium retention effect, and has a certain effect of promoting sodium and potassium excretion.

More

This product has a rapid effect and is one of the most potent topical corticosteroids currently used in clinical practice. It has a strong capillary constriction effect, and its anti-inflammatory effect is 112.5 times that of hydrocortisone, 2.3 times that of betamethasone sodium phosphate, and 18.7 times that of fluocinolone. The systemic adverse reactions are 3 times that of fluocinolone, and it has no sodium retention effect, and has a certain effect of promoting sodium and potassium excretion.

523-87-5 10
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.